News

Columbia Roybal Pilot Study Publications

Feasibility of a remote heart rate variability biofeedback intervention for reducing anxiety in cardiac arrest survivors: A pilot trial.

Birk, J. L., Cumella, R., Lopez-Veneros, D., Agarwal, S., & Kronish, I. M.  

Contemporary Clinical Trials Communications. 2024

Acceptance and Mindfulness-Based Exposure Therapy for PTSD After Cardiac Arrest: An Open Feasibility Trial

Bergman M, Markowitz JC, Kronish IM, Agarwal S, Fisch CT, Eder-Moreau E, Neria Y.

J Clin Psychiatry. 2023

Family-authored ICU diaries to reduce fear in patients experiencing a cardiac arrest (FAID fear): A pilot randomized controlled trial.

Cornelius T, Mendieta M, Cumella RM, Lopez Veneros D, Tincher IM, Agarwal S, Kronish I.

PLoS One. 2023 Jul 27

Psychological distress after sudden cardiac arrest and its impact on recovery.

Agarwal S, Birk J, Abukhadra S, Rojas D, Cornelius T, Bergman M, Chang B, Edmondson D, Kronish IM.

Current cardiology reports. 2022 Oct

Initial assessment of the feasibility and efficacy of a scalable digital CBT for generalized anxiety and associated health behaviors in a cardiovascular disease population.

Parsons ME, Hiserodt M, Otto MW.

ScienceDirect. 2023 Jan.

Other Publications

Improving the rigor of mechanistic behavioral science: the introduction of the checklist for investigating mechanisms in behavior-change research (CLIMBR).

Birk J, Otto MW, Cornelius T, Poldrack RA, Edmondson, D.

Behavior Therapy. 2023.

COVID-19 and the amplification of cardiovascular risk by psychological distress.

Kronish IM, Shechter A.

Nature Cardiovascular Research. 2022 November.

Psychological distress after sudden cardiac arrest and its impact on recovery.

Agarwal S, Birk J, Abukhadra S, Rojas D, Cornelius T, Bergman M, Chang B, Edmondson D, Kronish IM. (2022).

Current Cardiology Reports. 2022 Oct.

Association of depression and COVID-induced PTSD with cognitive symptoms after COVID-19 illness.

Liyanage-Don NA, Winawer MR, Hamberger MJ, Agarwal S, Trainor AR, Quispe KA, Kronish IM.

General Hospital Psychiatry. 2022 May.

The association of transmission concerns and social distance from loved ones with distress in medical professionals providing care during the COVID-19 pandemic in New York City.

Cornelius T, Duran AT, Diaz F, Bramley S, Shaw K, Schwartz JE, Edmondson D, Shechter A, Abdalla M.

Families, systems & health : the journal of collaborative family healthcare. 2021 September.

Psychological distress, persistent physical symptoms, and perceived recovery after COVID-19 illness.

Liyanage-Don NA, Cornelius T, Sanchez, JE, Trainor A, Moise N, Wainberg M, Kronish IM.

Journal of General Internal Medicine. 2021 Aug.

Hospital readmissions after implementation of a discharge care program for patients with COVID-19 illness.

Ye S, Hiura G, Fleck E, Garcia A, Geleris J, Lee P, Liyanage-Don N, Moise N, Schluger N, Singer J, Sobieszczyk M, Sun Y, West H, Kronish IM

Journal of General Internal Medicine. 2021 March.

Medications as Traumatic Reminders in Patients With Stroke/Transient Ischemic Attack-Induced Posttraumatic Stress Disorder.

Liyanage-Don N, Birk J, Cornelius T, Sanchez G, Moise N, Edmondson D, Kronish I.

Stroke. 2021 Jan.

Impact of prior trauma exposure on the development of PTSD symptoms after suspected acute coronary syndrome.

Young J, Schweber A, Sumner JA, Chang BP, Cornelius T, Kronish IM.

General Hospital Psychiatry. 2021 January.

Intervening on fear after acute cardiac events: Rationale and design of the INFORM randomized clinical trial.

Birk JL, Cumella R, Lopez-Veneros D, Jurado A, Romero EK, Lazarov A, Kronish IM.

Health Psychology. 2020 Sep.

Psychological distress, coping behaviors, and preferences for support among New York healthcare workers during the COVID-19 pandemic.

Shechter A, Diaz F, Moise N, Anstey DE, Ye S, Agarwal S, Birk JL, Brodie D, Cannone DE, Chang B, Claassen J, Cornelius T, Derby L, Dong M, Givens RC, Hochman B, Homma S, Kronish IM, Lee SAJ, Manzano W, Mayer LES, McMurry CL, Moitra V, Pham P, Rabbani L, Rivera RR, Schwartz A, Schwartz JE, Shapiro PA, Shaw K, Sullivan AM, Vose C, Wasson L, Edmondson D, Abdalla M.

General Hospital Psychiatry. 2020 September.

Posttraumatic Stress Disorder and Electronically Measured Medication Adherence After Suspected Acute Coronary Syndromes.

Kronish IM, Cornelius T, Schwartz JE, Shechter A, Diaz KM, Romero EK, Edmondson D.

Circulation. 2020 Aug 25.


Abstracts

Cumella R, Lopez-Veneros D, Kronish IM, Edmondson D, Birk JL. Heart rate variability biofeedback to reduce psychological distress in patients after acute cardiac events: A pilot study. American Psychosomatic Society; March 2020.

Birk J, Lopez-Veneros D, Cumella R, Agarwal S, Kronish IM. Surmounting the challenges of adapting a behavioral intervention for remote delivery during the COVID-19 pandemic: A case study of heart rate variability biofeedback training in cardiac arrest survivors. American Psychosomatic Society Virtual Meeting. December 2020.

Duran AT, Stravolakes K, Keteyian SJ, Kronish IM, Ye S, Moise N. The Implications of COVID-19 on cardiac rehabilitation: the need for theory-driven, telehealth-enhanced, non-traditional models. Academy Health Dissemination and Implementation Conference. Virtual conference. December 2020.


Articles & Features

A Novel Approach to Treating PTSD in Sudden Cardiac Arrest Survivors Cardiology, Neurology, and Psychiatry at New York-Presbyterian. 2024

"Sudden cardiac death and post-traumatic stress disorder: More research is needed" Contemporary Clinical Trials Communications. 2024

“Adopting Healthy Habits: What Do We Know about the Science of Behavior Change?” National Institute on Aging, U.S. Department of Health and Human Services, 4 Oct. 2022.

"What Happens When You Become Afraid of Health Care", Columbia University Irving Medical Center, March 13, 2023

A documentary about a massive neuroscience study that challenges the medical industry’s approach to chronic pain. Pain Brain. https://painbrainfilm.com - featuring Columbia Roybal Center PI: Dr. Yoni Ashar.


Presentations

"The Role of Mechanism Discovery and Targeting in the NIH Stage Model", May 2020

Donald Edmondson, PhD

“Fear and Avoidance after Acute Cardiovascular Events”, June 2020

Ian M. Kronish, MD, MPH

Translational Research Institute of Pain in Later Life (TRIPLL)  

Webinar series, Mechanisms and Management of Later Life Pain 


“PTSD after Acute Cardiovascular Events: Lessons for COVID”, June 2020

Ian M. Kronish, MD, MPH

Cleveland Clinic, Department of Psychiatry Grand Rounds 


“Piloting interventions to improve health behaviors after acute medical events”, Oct 2020

Ian M. Kronish, MD, MPH

Department of Medicine, Clinical/Epidemiological Research Seminar Series 

Grand Rounds Past Events

  • Toward a biopsychosocial model of care in neurology; From the Neuro-ICU to outpatient specialty clinics.

    • Presented by Ana-Maria Vranceanu, PhD | November 15, 2023

    Dr. Ana-Maria Vranceanu is a clinical psychologist and director of the Center for Health Outcomes and Interdisciplinary Research at Massachusetts General Hospital. She is also an associate professor of psychology at Harvard Medical School and the James and Elizabeth Gamble Endowed Chair Co-director for MassGeneral Neurosciences. She conducts research at the intersection of psychology and medicine, with a focus on the development, testing and implementation of psychosocial interventions for patients, caregivers and dyads across the disease trajectory, in both hospital and community settings. She co-leads the Lifespan Track of the APA approved MGH/HMS internship in clinical psychology, and the NIA funded MGH Bridge the Gap T32, the NIA funded Research and Education Core of the MGH Resource Center for Minority Aging Research. With support from an NCCIH K24 she developed and runs a successful "K club" which brings together interdisciplinary trainees and junior faculty who are either developing or executing career development awards.

    Headshot of Dr. Ana-Maria Vranceanu
  • Preventing Post-Traumatic Distress Disorder (PTSD) after an ICD Shock

    • Presented by Cynthia M. Dougherty ARNP, PhD, FAHA, FAAN| April 17, 2023

    Dr. Dougherty is the Spence Endowed Professor in Nursing at the University of Washington School of Nursing, Adjunct Professor in the Department of Medicine, Division of Cardiology, and an adult nurse practitioner in Cardiology at the VA Puget Sound Health Care System-Seattle, WA. Dr. Dougherty is a nationally and internationally recognized expert on recovery of physical functioning, psychological adjustment, and quality of life in persons who have suffered sudden cardiac arrest and have received an ICD. She has conducted trailblazing research in exercise after an ICD, caregiver interventions after ICD implantation, and goals of care communication in advanced heart failure. Dr. Dougherty is a rare nurse scientist who bridges what is too often a chiasm between nursing research and nursing practice.  Dr. Dougherty leads a large interdisciplinary research team, building a program of research that began by systematically characterizing the experiences of those who survived cardiac arrest in Seattle, WA, the home of pioneering work in resuscitation science. The impact of her work is evident in more than 100 publications and an excess of $20 million in research funding.

    Headshot of Dr. Cynthia Dougherty
  • Two of Hearts | Relationship Quality and Cardiovascular Health

    • Presented by Dr. Heather Tulloch | Nov 11, 2022

    Dr. Tulloch will review the importance of social relationships for cardiovascular health, discuss plausible mechanisms by which relationship quality impacts heart health, and describe her research on the Healing Hearts Together program, a couples-based interventions for patients with CVD and their partners.

    Dr. Heather Tulloch is the Senior Psychologist at the University of Ottawa Heart Institute (UOHI), co-Chair of the Patient Partnership Council, and Director of the Cardiovascular Health Psychology lab at the University of Ottawa Heart Institute. She is an Associate Professor in the Faculty of Medicine and cross-appointed to the School of Psychology at the University of Ottawa. She is a member of the Women’s Heart Team and the Transplant Team at UOHI, as well as the Canadian Women’s Heart Health Alliance. Dr. Tulloch main research focus is on the development and evaluation of psychosocial interventions to improve mental health, quality of life, and CVD outcomes among cardiac patients and their partners. She provides psychological assessment and treatment services to patients with cardiovascular disease and their partners.

    Headshot of Dr. Heather Tulloch
  • Cardiac-disease-induced-PTSD: Novel individual and dyadic perspectives

    • Presented by Noa Vilchinsky, PhD | Jul 27, 2022

    In the current lecture, I wish to suggest that cardiac–disease-induced PTSD (CDI-PTSD) is indeed a valid diagnostic entity, although manifested in symptoms with unique content; that it affects both patients and caregivers; and that dyadic dynamics among couples are critical for understanding the emergence and stability of CDI-PTSD over time.

    Noa Vilchinsky is an Associate Professor and the head of the Psycho-cardiology Research Lab, Department of Psychology, Bar Ilan University, Ramat Gan, Israel. She is also a certified rehabilitation psychologist, who worked many years with individuals and families coping with cardiac illnesses. Her main fields of research are psycho-cardiology, dyadic coping with chronic illness, caregiving in health challenges, attitudes toward people with disabilities, and the importance of being treated with dignity in the medical setting. Prof.  Vilchinsky serves as the Secretary of the European Health Psychology Society (EHPS).

    Headshot Dr. Noa Vilchinsky
  • ACS-induced posttraumatic stress symptoms: features, consequences and treatment options

    • Presented by Mary Princip, PhD | May 23, 2022

    The first part of the presentation includes special features of ACS-induced PTSD, known predictors and consequences. In the second part of the presentation, I will focus on the results of our research group in Switzerland (Prof. Dr. med. Roland von Känel) and our current projects running at the University Hospital in Zurich. Therapeutic recommendation for the treatment of ACS-induced PTSD patients regarding research findings and clinical practice forms the conclusion.

    Dr. Mary Princip’s deepest interest is combining research with clinical work. For her master’s thesis she worked on a project that examined whether sleep could increase the effectiveness of virtual exposure therapy in patients with arachnophobia. After her studies, she began her four-year training as a psychological psychotherapist with a cognitive-behavioral focus in 2011 and worked as clinical psychologist. She looked after adults with a wide range of mental illnesses and carried out assessments of attention deficit and hyperactivity disorder (ADHD) in adulthood. To pursue her research interests, she started her PhD in the field of psychocardiology at the Inselspital Bern in 2013.

    From 2013 to 2015 Dr. Princip, alongside PI: Prof. Dr. med. Roland von Känel, carried out a study to examine posttraumatic stress after an acute myocardial infarction as part of a project funded by the Swiss National Science Foundation “MI-SPRINT – Myocardial Infarction Stress Prevention Intervention”. In this way, she was able to conduct a semi-structured consultation with a large number of patients who suffered from considerable stress from the heart attack, and at the follow-up appointments learned how to assess posttraumatic stress using a standardized clinical interview (CAPS). This project raised her enthusiasm for psychocardiology, which, as a still young field of research, offers many possibilities for clinically relevant research questions. In addition to her PhD, she was able to look after patients as a case-leading psychotherapist at the Inselspital in the department of psychosomatics and continue to gain in-depth clinical experience. Following her PhD, she headed the outpatient area of cardiac rehabilitation at the University Hospital / Inselspital Bern as a psychocardiologist from 2015-2018 and was responsible for the inpatient area of psychocardiology. 

    As part of cardiac rehabilitation, Dr. Princip was a psychotherapist for patients with heart disease, conducted psycho-educational group courses with patients and their relatives, and was actively involved in congresses. In addition, she was involved in teaching and trained nurses in the field of psychocardiology. During her work as a psychocardiologist, she also completed the advanced training course in psychocardiology in Göttingen (Germany) and qualified for "Eye Movement Desensitization and Reprocessing" - EMDR therapist. 3.5 years ago, she was able to take another step toward combining clinical and research activities on her academic path. 

    In order to be able to carry out her clinical work more independently and at the same time to devote herself more in depth to psychocardiological research, Dr. Princip switched to a psychiatric-psychotherapeutic group practice. At the same time, she was able to expand her research through a position as a senior assistant at the at the Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, and since 2018 has been aiming for her habilitation in the field of psychocardiology with great pleasure.

    Headshot of Mary Princip, PhD
  • Implicit Attitudes, Adaptive Change and Medication Adherence: a novel approach to a complex problem.

    • Presented by M.A. “Tonette” Krousel-Wood MD, MSPH, FACPM, FAHA | April 1, 2022

    M.A. “Tonette” Krousel-Wood MD, MSPH, FACPM, FAHA

    Professor of Medicine in the Tulane School of Medicine, Professor of Epidemiology in the Tulane School of Public Health and Tropical Medicine and serves in several leadership roles at Tulane including the Associate Provost for the Health Sciences, Senior Associate Dean of Faculty, and Associate Dean for Public Health and Medical Education at Tulane University.  

    As a physician-scientist, she leads several NIH-funded clinical research and clinical trials focused on adherence to prescribed therapies, management of hypertension, sex differences and health equity in health services and outcomes in patients with chronic cardiometabolic diseases and most recently COVID-19.  She has presented her research findings at regional, national, and international meetings and has collectively published over 150 peer-reviewed articles, reports and book chapters. She was recently awarded another R01 for a clinical trial to investigate a novel approach supporting adaptive change to improve adherence in older adults with hypertension.

    In addition to her own research, she is committed to training the next generation of scientists and leads pre- and post-doctoral career development programs including serving as the Principal Investigator and Research Director for the NIH K12 Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) faculty career development award and Principal Investigator for the Tulane Stimulating Access to Research in Residency (StARR) (R38). She also leads the MD/MPH program at Tulane—it is one of the oldest and largest programs of its kind in the US with over 1000 graduates since inception and serves as a model for combined medical and public health training of future physicians nationwide.

    Her past leadership positions nationally include member and Chair of the National Institutes of Health Study Section, Health Services Organization and Delivery, President of the Southern Society for Clinical Investigation, President of Delta Omega national public health honorary society, President of the American Board of Preventive Medicine, and member of the National Institutes of Health Center for Scientific Review (NIH-CSR) Advisory Council. She is currently the President and Fellow of the American College of Preventive Medicine and Fellow of the American Heart Association.

    Headshot of Dr. M.A. “Tonette” Krousel-Wood
  • Internet-delivered Exposure-based Cognitive Behavior Therapy for Arial Fibrillation

    • Presented by Josefin Särnholm, PhD | January 19, 2022

    Josefin Särnholm, PhD, is a researcher and faculty member at the Department of Clinical Neuroscience, Division of Psychology, Karolinska Institutet, Stockholm, Sweden. Dr Särnholm completed her doctoral training at Karolinska Institutet where she developed a novel CBT treatment for atrial fibrillation (AF) that was tested in the world’s first randomized controlled trial of CBT for AF. Her work focuses on developing scalable internet-delivered, exposure-based treatments targeting avoidance behavior and cardiac anxiety in patients with cardiac disease. She has participated in a wide range of clinical trials for a somatic and psychiatric disorders and is currently involved in a number of clinical studies on the effect of CBT. Dr Särnholm is also a licensed psychologist with extensive experience in treating anxiety disorders and administering psychological treatment for somatic diseases. She is also a clinical lecturer and teaches at the clinical psychologist program at Karolinska Institutet.

    Josefin Sarnholm headshot
  • Can A Novel Psychological Treatment Eliminate Primary Chronic Pain?

    • Presented by Yoni K. Ashar, PhD | November 17, 2021

    Yoni K. Ashar, PhD is a TL1-funded postdoctoral associate in the department of psychiatry at Weill Cornell Medicine, under the co-mentorship of Drs. Conor Liston and Faith Gunning. He completed his doctorate in clinical psychology and neuroscience at the University of Colorado Boulder, under the co-mentorship of Drs. Tor Wager and Sona Dimidjian.

    Yoni Ashar headshot
  • Innovations in the Treatment of PTSD

    • Presented by Barbara O. Rothbaum, PhD | July 26, 2021

    Barbara Olasov Rothbaum, PhD is Director of the Emory Healthcare Veterans Program. She is a professor and Associate Vice Chair of Clinical Research at Emory School of Medicine in the Department of Psychiatry and Behavioral Sciences and Director of the Trauma and Anxiety Recovery Program and holds the Paul A. Janssen Chair in Neuropsychopharmcology. Dr. Rothbaum specializes in research on the treatment of anxiety disorders, particularly PTSD. She was a member of the Institute of Medicine’s (IOM) Study on Assessment of Ongoing Efforts in the Treatment of PTSD, and briefed the DOD, VA, House and Senate Committees on Veterans Affairs and Armed Services Committees on the IOM report results. Dr. Rothbaum has been studying PTSD treatments since 1986 and has developed, tested, and disseminated some of the most innovative and effective treatments available for PTSD. She is an inventor of virtual reality exposure therapy. She was a pioneer in applying it in the treatment of PTSD in combat veterans. She has authored over 400 scientific papers and chapters, has published 11 books on the treatment of PTSD and edited 4 others on anxiety, and received the Diplomate in Behavioral Psychology from the American Board of Professional Psychology. She is a past president of the International Society of Traumatic Stress Studies (ISTSS), is currently on the Scientific Advisory Boards for the Anxiety Disorders Association of America (ADAA), National Center for PTSD (NC-PTSD), and the executive committee of the Warrior Care Network. She is a fellow of the ACNP (American College of Neuropsychopharmacology), the National Academy of Inventors (NAI), the Association for Behavioral and Cognitive Therapies (ABCT), and American Psychological Association’s Division 56 (Division of Trauma Psychology) and was awarded the 2010 “Award for Outstanding Contributions to the Practice of Trauma Psychology” for APA Division 56 and the Robert S. Laufer Award for Outstanding Scientific Achievement from the International Society for Traumatic Stress Studies (ISTSS).

    Barbara Rothbaum headshot
  • Developing and Testing Positive Psychology-based Interventions to Promote Physical Activity

    • Presented by Jeff Huffman, MD | June 1, 2021

    Dr. Huffman is a Professor of Psychiatry at Harvard Medical School and the Director of the Cardiac Psychiatry Research Program.  His work has focused on developing scalable clinical interventions to improve mental health and health behaviors in people with heart disease and related medical conditions. This includes developing a positive psychology-based intervention program to promote physical activity among patients with recent acute cardiac events and those with more chronic conditions.  His work has led to more than 180 peer-reviewed publications, and he has received funding from multiple NIH institutes, the American Heart Association, the American Diabetes Association, and the Templeton Foundation.  

    Jeff Huffman headshot
  • Prevention of ACS-induced Posttraumatic Stress: Lessons Learned from a Randomized Controlled Trial

    • Presented by Roland von Känel, MD | May 10, 2021

    Roland von Känel, MD, is Chair of Consultation-Liaison Psychiatry and Psychosomatic Medicine at the University of Zurich and Director of the Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine at the University Hospital Zurich. He is an internist, psychiatrist and psychotherapist, specialized in psychosomatic medicine. His research interests include biobehavioral pathways linking psychological stress with the development and clinical manifestation of cardiovascular diseases.

    Roland Von Kanel headshot
  • Targeting Fear and Avoidance of Exercise in Cardiac Rehabilitation

    • Presented by Samantha Farris, PhD | February 17, 2021

    On February 17, 2021, SOBC and the Columbia Roybal Center for Fearless Behavior Change co-hosted a Grand Rounds Webinar with Dr. Samantha Farris who presented on Targeting Fear and Avoidance of Exercise in Cardiac Patients.

    Talk Description: Dr. Farris discussed her translational research on exercise fear-avoidance and the application of this work to cardiac rehabilitation. She defines the construct of ‘interoceptive sensitivity’ and describes its multi-method measurement, and then introduces an exposure-based behavioral intervention to target interoceptive sensitivity and improve physical activity outcomes in cardiac rehabilitation.

    Dr. Samantha Farris is an Assistant Professor in the Department of Psychology and is the Director of The Rutgers Emotion, Health and Behavior (REHAB) Laboratory. Dr. Farris received her Ph.D. in Clinical Psychology at The University of Houston and completed her psychology internship at the Alpert Medical School at Brown University. She completed fellowships in cancer prevention at the University of Texas MD Anderson Cancer Center and in cardiovascular behavioral medicine at The Miriam Hospital/Alpert Medical School at Brown University. Dr. Farris has published over 100 peer-reviewed publications and has received continuous funding for her research from the National Institutes of Health. Dr. Farris’ research focuses on understanding how and why stress and anxiety (i.e., worry, fear, panic) commonly co-occur with and contribute to problematic health behaviors and chronic disease. She utilizes an experimental medicine approach to (a) identify cognitive-affective mechanisms that contribute to health behaviors and physical disease, (b) isolate how these mechanisms influence health behaviors “in real time” through use of laboratory methodologies, and in turn (c) develop tailored interventions that target these mechanisms to promote health behavior change and prevent the onset or progression of chronic disease. Dr. Farris is also a licensed clinical psychologist in the state of New Jersey, New York, and Rhode Island, and specializes in cognitive-behavioral therapy for the treatment of anxiety and related disorders.

    Headshot of Dr. Samantha Farris
  • Clinical Neuroscience and the Heart-Brain Axis

    • Presented by Sarah Garfinkel, PhD | December 15, 2020

    Sarah Garfinkel is Professor at the Institute of Cognitive Neuroscience, University College London, where she leads the Clinical and Affective Neuroscience Group. She completed her PhD in Experimental Psychology the University of Sussex, before undergoing a training fellowship in Psychiatry and Neuroscience at the University of Michigan. Her current work focuses on brain-body interactions underlying emotion and cognition, with a particular focus on the heart. Adopting a translational perspective, she investigates altered cardiac-neural mechanisms in different clinical conditions such as anxiety, in order to devise novel clinical interventions. In September 2018, Sarah was named by the journal Nature as one of 11 "Rising Star" researchers, across all STEM disciplines internationally, and the only scientist to be selected from the UK. Sarah is also involved in the public engagement of science where she contributes to science programmes on BBC TV and radio.  

    Sarah Garfinkel Headshot
  • Digital Therapeutics for Health Behavior Change: The State of the Science

    • Presented by Lisa A. Marsch, PhD | October 27, 2020

    Lisa A. Marsch, PhD is the Director of the Center for Technology and Behavioral Health (CTBH), the Director of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network, and the Andrew G. Wallace Professor within the Geisel School of Medicine at Dartmouth College. CTBH is an interdisciplinary “Center of Excellence”, supported by the U.S. National Institute on Drug Abuse, which uses science to inform the development, evaluation, and sustainable implementation of digital therapeutics (that leverage web, mobile, sensing and/or social media approaches) in the treatment of persons with substance use disorders and other behavioral health challenges. These tools are designed to deliver engaging and effective health monitoring and health behavior interventions to collectively lead to transformations in the delivery of science-based behavioral health treatment.

    Headshot of Lisa Marsch
  • Pilot Trials of Health-Related Behavioral Interventions: Problems, Solutions, and Recommendations

    • Presented by Kenneth Freedland, PhD | October 19, 2020

    Dr. Kenneth Freedland is a Professor of Psychiatry and Psychology at Washington University School of Medicine in St. Louis, the Editor-in-Chief of Health Psychology, and the Program Director of the annual NIH/OBSSR Summer Institute on Randomized Behavioral Clinical Trials. His methodological interests include feasibility and pilot studies and the selection and design of comparators for randomized controlled trials of health-related behavioral interventions. He chaired the NIH/OBSSR Expert Panel on Comparator Group Selection in Behavioral and Social Science Clinical Trials and has published several papers and chapters on comparators and on pilot studies.

    He is also the developer of the Purpose-Guided Trial Design (PGTD) framework for behavioral interventions. His clinical research focuses primarily on the role and treatment of depression, stress, anxiety, and self-care in patients with heart disease. He has been involved in clinical research on patients with other chronic medical conditions as well. He was a co-investigator and clinical supervisor for the ENRICHD multicenter trial and has been the principal investigator or a co-investigator of a number of single-site clinical trials, a dual-site trial of stress management for lung transplant candidates, and the CODIACS multicenter vanguard trial of stepped care for depression in patients with coronary heart disease. He has served as the clinical supervisor for the intervention arms of a number of depression treatment trials for patients with chronic medical conditions. He has served on several NIH study sections and NIH and VA special emphasis panels, the Clinical Trials Review Committee for the National Heart, Lung, and Blood Institute, and the DSMBs for several randomized controlled trials. Dr. Freedland was an Associate Editor of Psychosomatic Medicine for over 10 years, chaired the Publications and Communications Council of the Society of Behavioral Medicine, is the Associate Editor for Behavioral Medicine for the Hogrefe series on Advances in Psychotherapy: Evidence-Based Practice, and is currently the Editor-in-Chief of Health Psychology. He is a fellow of the American Heart Association, the Society of Behavioral Medicine, and the Academy of Cognitive Therapy (ACT); a former member of Council of the American Psychosomatic Society; past Chair of the American Heart Association’s Behavior Change Committee; past President and Treasurer of the Academy of Behavioral Medicine Research, and the founder of the Behavioral Medicine Research Council.

    Reference: Freedland KE. Pilot trials in health-related behavioral intervention research: Problems, solutions, and recommendations. Health Psychology 2020 Oct;39(10):851-862. doi: 10.1037/hea0000946. Epub 2020 Jul 2. PMID: 32614197.

    Headshot of Dr. Kenneth Freedland

Newsletters